Treatment of hind limb ischemia using angiogenic peptide nanofibers

For a proangiogenic therapy to be successful, it must promote the development of mature vasculature for rapid reperfusion of ischemic tissue. Whole growth factor, stem cell, and gene therapies have yet to achieve the clinical success needed to become FDA-approved revascularization therapies. Herein,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Biomaterials
Main Authors: Kumar, Vivek A., Liu, Qi, Wickremasinghe, Navindee C., Shi, Siyu, Cornwright, Toya T., Deng, Yuxiao, Azares, Alon, Moore, Amanda N., Acevedo-Jake, Amanda M., Agudo, Noel R., Pan, Su, Woodside, Darren G., Vanderslice, Peter, Willerson, James T., Dixon, Richard A., Hartgerink, Jeffrey D.
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4905688/
https://ncbi.nlm.nih.gov/pubmed/27182813
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.biomaterials.2016.04.032
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados